Current Neuro-Oncology
Volume
2 Number 11
30 November 2000
Home > Publications > Current Neuro-Oncology > Volume 2, Year 2000 > Number 11, 30 November
Beauchesne P, Soler C, Mosnier
JF.
Diffuse
vertebral body metastasis from a glioblastoma multiforme: a
technetium-99m Sestamibi single-photon emission computerized
tomography study.
J
Neurosurg. 2000 Nov;93(5):887-90∟.
doi: 10.3171/jns.2000.93.5.0887∟.
PMID: 11059674∟.
Case report.
Muanza T, Shenouda G, Souhami L,
Leblanc R, Mohr G, Corns R, Langleben A.
High
dose tamoxifen and radiotherapy in patients with glioblastoma
multiforme: a phase IB study.
Can
J Neurol Sci. 2000 Nov;27(4):302-6∟.
doi: 10.1017/s0317167100001049∟.
PMID: 11097520∟.
Interventional study.
Kumar AJ, Leeds NE, Fuller GN, Van
Tassel P, Maor MH, Sawaya RE, Levin VA.
Malignant
gliomas: MR imaging spectrum of radiation therapy- and
chemotherapy-induced necrosis of the brain after
treatment.
Radiology.
2000 Nov 1;217(2):377-84∟.
doi: 10.1148/radiology.217.2.r00nv36377∟.
PMID: 11058631∟.
Observational study.
Sandmair AM, Loimas S, Puranen P,
Immonen A, Kossila M, Puranen M, Hurskainen H, Tyynelä K,
Turunen M, Vanninen R, Lehtolainen P, Paljärvi L, Johansson
R, Vapalahti M, Ylä-Herttuala S.
Thymidine
kinase gene therapy for human malignant glioma, using
replication-deficient retroviruses or adenoviruses.
Hum
Gene Ther. 2000 Nov 1;11(16):2197-205∟.
doi: 10.1089/104303400750035726∟.
PMID: 11084677∟.
Interventional study.
Yu JS, Yong WH, Wilson D, Black
KL.
Glioblastoma
induction after radiosurgery for meningioma.
Lancet.
2000 Nov 4;356(9241):1576-7∟.
doi: 10.1016/S0140-6736(00)03134-2∟.
PMID: 11075777∟.
Case report.
*
Aboody KS, Brown A, Rainov NG,
Bower KA, Liu S, Yang W, Small JE, Herrlinger U, Ourednik V, Black
PM, Breakefield XO, Snyder EY.
Neural
stem cells display extensive tropism for pathology in adult brain:
evidence from intracranial gliomas.
Proc
Natl Acad Sci USA. 2000 Nov 7;97(23):12846-51∟.
doi: 10.1073/pnas.97.23.12846∟.
PMID: 11070094∟.
Laboratory investigation.
Erratum
in: Proc Natl Acad Sci USA. 2001 Jan 16;98(2):777∟.
doi: 10.1073/pnas.98.2.777-d∟.
Correction.
Esteller M, Garcia-Foncillas J,
Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, Baylin SB, Herman
JG.
Inactivation
of the DNA-repair gene MGMT and the clinical response of gliomas
to alkylating agents.
N
Engl J Med. 2000 Nov 9;343(19):1350-4∟.
doi: 10.1056/NEJM200011093431901∟.
PMID: 11070098∟.
Observational study.
Erratum
in: N Engl J Med 2000 Dec 7;343(23):1740∟.
doi: 10.1056/NEJM200012073432320∟.
Correction.
Cokgor I, Akabani G, Kuan CT,
Friedman HS, Friedman AH, Coleman RE, McLendon RE, Bigner SH, Zhao
XG, Garcia-Turner AM, Pegram CN, Wikstrand CJ, Shafman TD, Herndon
JE 2nd, Provenzale JM, Zalutsky MR, Bigner DD.
Phase
I trial results of iodine-131-labeled antitenascin monoclonal
antibody 81C6 treatment of patients with newly diagnosed malignant
gliomas.
J Clin
Oncol. 2000 Nov 15;18(22):3862-72∟.
doi: 10.1200/JCO.2000.18.22.3862∟.
PMID: 11078500∟.
Interventional study.
Wolff JE, Mölenkamp G,
Westphal S, Pietsch T, Gnekow A, Kortmann RD, Kuehl J.
Oral
trofosfamide and etoposide in pediatric patients with glioblastoma
multiforme.
Cancer.
2000 Nov 15;89(10):2131-7∟.
doi:
10.1002/1097-0142(20001115)89:10<2131::aid-cncr14>3.0.co;2-j∟.
PMID: 11066055∟.
Interventional study.
Rainov NG.
A
phase III clinical evaluation of herpes simplex virus type 1
thymidine kinase and ganciclovir gene therapy as an adjuvant to
surgical resection and radiation in adults with previously
untreated glioblastoma multiforme.
Hum
Gene Ther. 2000 Nov 20;11(17):2389-401∟.
doi: 10.1089/104303400750038499∟.
PMID: 11096443∟.
Interventional study.
Coughlin
C, Scott C, Langer C, Coia L, Curran W, Rubin P.
Phase
II, two-arm RTOG trial (94-11) of bischloroethyl-nitrosourea plus
accelerated hyperfractionated radiotherapy (64.0 or 70.4 Gy) based
on tumor volume (> 20 or < or = 20 cm2,
respectively) in the treatment of newly-diagnosed
radiosurgery-ineligible glioblastoma multiforme patients.
Int
J Radiat Oncol Biol Phys. 2000 Nov 27;48(5):1351-8∟.
doi: 10.1016/s0360-3016(00)01412-7∟.
PMID: 11121633∟.
Interventional study.
Gamburg ES, Regine WF, Patchell RA,
Strottmann JM, Mohiuddin M, Young AB.
The
prognostic significance of midline shift at presentation on
survival in patients with glioblastoma multiforme.
Int
J Radiat Oncol Biol Phys. 2000 Nov
27;48(5):1359-62∟.
doi: 10.1016/s0360-3016(00)01410-3∟.
PMID: 11121634∟.
Observational study.
Jacobsson SO, Rongård E,
Stridh M, Tiger G, Fowler CJ.
Serum-dependent
effects of tamoxifen and cannabinoids upon C6 glioma cell
viability.
Biochem
Pharmacol. 2000 Nov 30;60(12):1807-13∟.
doi: 10.1016/s0006-2952(00)00492-5∟.
PMID: 11108795∟.
Laboratory investigation.
Park JR, Slattery J, Gooley T, Hawkins D, Lindsley K, Villablanca
JG, Matthay KK, Sanders JE.
Phase I
topotecan preparative regimen for high-risk neuroblastoma,
high-grade glioma, and refractory/recurrent pediatric solid
tumors.
Med Pediatr Oncol. 2000 Nov 30;35(6):719-23∟.
doi: 10.1002/1096-911x(20001201)35:6<719::aid-mpo52>3.0.co;2-v∟.
PMID: 11107155∟.
Interventional study.